Company intelligence / Profile preview

Adipharm

Ownership: Private
Development stage: Other

Overview

Adipharm manufactures and exports a wide range of prescription and OTC medicines and food supplements, with over 120 registered products and commercial operations across more than 30 countries. The company adheres to GMP standards and operates significant export and out-licensing activities for generic pharmaceuticals. No information was found about clinical trials for novel drugs or advanced therapeutic programs.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Adipharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adipharm.